Silver Book Fact

Direct medical costs for treatment of atrial fibrillation, 2001

The direct medical costs for ambulatory and outpatient treatment of atrial fibrillation patients in 2001 was  an estimated $1.76 billion. Office visits accounted for 66% of those costs, emergency department visits for 17%, and hospital outpatient department visits for 16%.

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • AFib prevalence estimates
    Atrial fibrillation is the most common heart arrhythmia in the U.S. Often going undiagnosed, AFib prevalence estimates vary between 2.7 million and 6.1 million Americans.  
  • Age as a risk factor of Afib
    At age 60, 1 in 25 Americans have AFib. At age 80+, this increases to nearly 1 in 10.  
  • Atrial fibrillation prevalence projection, 2050
    Atrial fibrillation prevalence is projected to rise to between 5.6 and 12.1 million in 2050.  
  • Atrial fibrillation as a contributory cause of death
    Around 84% of all deaths with atrial fibrillation as a contributory cause are in individuals age 75 and older.  
  • Annual cost of AFib-related stroke in Medicare patients
    The annual cost of stroke in Medicare patients with atrial fibrillation is estimated at $8 billion.